{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:44:58Z","timestamp":1787031898374,"version":"build-2736575974"},"reference-count":22,"publisher":"The Fukushima Society of Medical Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.5387\/fms.25-00003","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T18:09:42Z","timestamp":1747418982000},"page":"277-282","source":"Crossref","is-referenced-by-count":1,"title":["Dasatinib-related diffuse alveolar hemorrhage in de novo blast phase chronic myeloid leukemia: a case report"],"prefix":"10.5387","volume":"71","author":[{"given":"Kengo","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Fukuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fukatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Koyama D, Kikuchi J, Kuroda Y, Ohta M, Furukawa Y. AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells. Cancer Sci, <b>112<\/b>(1):194-204, 2021.","DOI":"10.1111\/cas.14698"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Uchida Y, Koyama D, Manabe K, Suzuki K, Asano N, Endo M, <i>et al.<\/i> High Efficacy and Safety of Asciminib in a Chronic Myeloid Leukemia Patient with Chronic Kidney Disease Following Renal Transplantation:A Case Report. Intern Med, 2023.","DOI":"10.2169\/internalmedicine.2179-23"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, <i>et al.<\/i> Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med, <b>376<\/b>(10):917-927, 2017.","DOI":"10.1056\/NEJMoa1609324"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cross NCP, Ernst T, Branford S, Cayuela JM, Deininger M, Fabarius A, <i>et al.<\/i> European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. Leukemia, <b>37<\/b>(11):2150-2167, 2023.","DOI":"10.1038\/s41375-023-02048-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oh I, Hatano K, Ikeda T, Toda Y, Minakata D, Kawaguchi S, <i>et al.<\/i> Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults. Leuk Res, <b>137<\/b>:107438, 2024.","DOI":"10.1016\/j.leukres.2024.107438"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, <i>et al.<\/i> Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood Adv, <b>6<\/b>(2):624-636, 2022.","DOI":"10.1182\/bloodadvances.2021004607"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers CL. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science, <b>305<\/b>(5682): 399-401, 2004.","DOI":"10.1126\/science.1099480"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R, <i>et al.<\/i> Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. J Clin Invest, <b>126<\/b>(9):3207-3218, 2016.","DOI":"10.1172\/JCI86249"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Daccord C, Letovanec I, Yerly P, Bloch J, Ogna A, Nicod LP, <i>et al.<\/i> First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension. Eur Respir J, <b>51<\/b>(3), 2018.","DOI":"10.1183\/13993003.01694-2017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ito Y, Tanigawa M, Iwamoto K, Nigi A, Itani H, Kondo S, <i>et al.<\/i> Interstitial pneumonitis associated with dasatinib:two case reports and literature review. Respir Investig, <b>57<\/b>(5):506-509, 2019.","DOI":"10.1016\/j.resinv.2019.06.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jais X, <i>et al.<\/i> Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors. Eur Respir J, <b>56<\/b>(4), 2020.","DOI":"10.1183\/13993003.00279-2020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sakoda Y, Arimori Y, Ueno M, Matsumoto T. A Suspected Case of an Alveolar Haemorrhage Caused by Dasatinib. Intern Med, <b>56<\/b>(2):203-206, 2017.","DOI":"10.2169\/internalmedicine.56.7363"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Otoshi T, Kataoka Y, Nakagawa A, Otsuka K, Tomii K. Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy:A Retrospective Cohort Study. Lung, <b>194<\/b>(3):475-481, 2016.","DOI":"10.1007\/s00408-016-9873-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lussi C, Christ M, Flomer F. Crazy Paving Pattern. Dtsch Arztebl Int, <b>115<\/b>(42):714, 2018.","DOI":"10.3238\/arztebl.2018.0714b"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hughes TP, Laneuville P, Rousselot P, Snyder DS, Rea D, Shah NP, <i>et al.<\/i> Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia. Haematologica, <b>104<\/b>(1):93-101, 2019.","DOI":"10.3324\/haematol.2018.188987"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Senapati J, Sasaki K, Issa GC, Lipton JH, Radich JP, Jabbour E, <i>et al.<\/i> Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood Cancer J, <b>13<\/b>(1):58, 2023.","DOI":"10.1038\/s41408-023-00823-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim Y, Lim J, Lim J, Kim S, Jung T, Choi W. Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction. Korean Circ J, <b>43<\/b>(7):497-949, 2013.","DOI":"10.4070\/kcj.2013.43.7.497"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oualim S, Elharda CA, Benzeroual D, Hattaoui ME. Pulmonary alveolar hemorrhage mimicking a pneumopathy:a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction. Pan Afr Med J, <b>24<\/b>:308, 2016.","DOI":"10.11604\/pamj.2016.24.308.8828"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ishida R, Nomura T, Kojima A, Urakabe Y, Enomoto S, Nishikawa S, <i>et al.<\/i> Pulmonary hemorrhage in a middle-aged woman as a complication of treatments for acute myocardial infarction. J Cardiol Cases, <b>1<\/b>(1):e37-e41, 2010.","DOI":"10.1016\/j.jccase.2009.07.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takekoshi D, Matsui Y, Akutsu T, Nishioka A, Kiritani A, Okuda K, <i>et al.<\/i> Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib. Intern Med, <b>59<\/b>(18):2297-2300, 2020.","DOI":"10.2169\/internalmedicine.4714-20"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, <i>et al.<\/i> Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. N Engl J Med, <b>391<\/b>(10):885-898, 2024.","DOI":"10.1056\/NEJMoa2400858"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dhara D, John K, Randa H, Saria T, Manish P. Dasatinib -induced diffuse alveolar hemorrhage. The Southwest Respiratory and Critical Care Chronicles,<b>9<\/b>(41), 2021.","DOI":"10.12746\/swrccc.v9i41.897"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/71\/4\/71_25-00003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:49:33Z","timestamp":1759549773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/71\/4\/71_25-00003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.25-00003","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-00003"}}